[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2149 Introduced in House (IH)]

<DOC>






117th CONGRESS
  1st Session
                                H. R. 2149

To provide that certain rules and guidance related to waivers for State 
 innovation under the Patient Protection and Affordable Care Act shall 
                        have no force or effect.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 23, 2021

 Ms. Kuster (for herself, Mr. Beyer, and Mr. Courtney) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
To provide that certain rules and guidance related to waivers for State 
 innovation under the Patient Protection and Affordable Care Act shall 
                        have no force or effect.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Americans with Pre-
existing Conditions Act of 2021''.

SEC. 2. PROVIDING THAT CERTAIN RULES AND GUIDANCE RELATED TO WAIVERS 
              FOR STATE INNOVATION UNDER THE PATIENT PROTECTION AND 
              AFFORDABLE CARE ACT SHALL HAVE NO FORCE OR EFFECT.

    (a) In General.--The Secretary of Health and Human Services and the 
Secretary of the Treasury may not take any action to implement, 
enforce, or otherwise give effect to the rules and guidance described 
in subsection (b), and no such rules and guidance shall have any force 
or effect.
    (b) Rules and Guidance.--The rules and guidance described in this 
subsection are the following:
            (1) The provisions in the final rule issued by the 
        Secretary of Health and Human Services and the Secretary of the 
        Treasury on January 19, 2021, relating to ``Updates to State 
        Innovation Waiver (Section 1332 Waiver) Implementing 
        Regulations'' (86 Fed. Reg. 6138).
            (2) The guidance issued by such Secretaries entitled 
        ``State Relief and Empowerment Waivers'' (83 Fed. Reg. 53575 
        (October 24, 2018)), or any other rule promulgated to give 
        effect to such guidance.
                                 <all>